Anticancer Effect of Benzimidazole Derivatives, Especially Mebendazole, on Triple-Negative Breast Cancer (TNBC) and Radiotherapy-Resistant TNBC In Vivo and In Vitro
Hoon Sik Choi(Gyeongsang National University), Bae Kwon Jeong(Gyeongsang National University)
Cited by 41
Related Papers
Mebendazole Increases Anticancer Activity of Radiotherapy in Radiotherapy-Resistant Triple-Negative Breast Cancer Cells by Enhancing Natural Killer Cell-Mediated Cytotoxicity
|International Journal of Molecular Sciences|2022|14